|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
19
|
|
pubmed:dateCreated |
2009-11-5
|
|
pubmed:abstractText |
Vulvar intraepithelial neoplasia is a chronic disorder caused by high-risk types of human papillomavirus (HPV), most commonly HPV type 16 (HPV-16). Spontaneous regression occurs in less than 1.5% of patients, and the rate of recurrence after treatment is high.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cancer Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/E6 protein, Human papillomavirus...,
http://linkedlifedata.com/resource/pubmed/chemical/Freund's Adjuvant,
http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Papillomavirus E7 Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Papillomavirus Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Repressor Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, Synthetic,
http://linkedlifedata.com/resource/pubmed/chemical/oncogene protein E7, Human...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:Berends-van der MeerDorien M ADM,
pubmed-author:DrijfhoutJan WouterJW,
pubmed-author:EssahsahFarahF,
pubmed-author:FathersLorraine MLM,
pubmed-author:FleurenGert JanGJ,
pubmed-author:KenterGemma GGG,
pubmed-author:LowikMargriet J GMJ,
pubmed-author:MeliefCornelis J MCJ,
pubmed-author:OffringaRienkR,
pubmed-author:OostendorpJaapJ,
pubmed-author:ValentijnA Rob P MAR,
pubmed-author:VloonAnnelies P GAP,
pubmed-author:WafelmanAmon RAR,
pubmed-author:WeltersMarij J PMJ,
pubmed-author:van der BurgSjoerd HSH
|
|
pubmed:copyrightInfo |
Copyright 2009 Massachusetts Medical Society.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
5
|
|
pubmed:volume |
361
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1838-47
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19890126-Adult,
pubmed-meshheading:19890126-Cancer Vaccines,
pubmed-meshheading:19890126-Carcinoma in Situ,
pubmed-meshheading:19890126-Female,
pubmed-meshheading:19890126-Freund's Adjuvant,
pubmed-meshheading:19890126-Human papillomavirus 16,
pubmed-meshheading:19890126-Humans,
pubmed-meshheading:19890126-Middle Aged,
pubmed-meshheading:19890126-Oncogene Proteins, Viral,
pubmed-meshheading:19890126-Papillomavirus E7 Proteins,
pubmed-meshheading:19890126-Papillomavirus Infections,
pubmed-meshheading:19890126-Papillomavirus Vaccines,
pubmed-meshheading:19890126-Repressor Proteins,
pubmed-meshheading:19890126-T-Lymphocytes,
pubmed-meshheading:19890126-Treatment Outcome,
pubmed-meshheading:19890126-Vaccines, Synthetic,
pubmed-meshheading:19890126-Vulvar Neoplasms,
pubmed-meshheading:19890126-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.
|
|
pubmed:affiliation |
Department of Gynecology, Leiden University Medical Center, Leiden, The Netherlands. g.g.kenter@lumc.nl
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
